High-risk factors for metabolic bone disease in very low birth weight infants: a multicentre retrospective study

Yuyun Chen,Jian Yang,Yi Wang,Wei Liu,Zhenhua Guo
DOI: https://doi.org/10.21203/rs.3.rs-1932908/v1
2022-01-01
Abstract:Abstract Background: The occurrence of metabolic bone disease in preterm newborns is not uncommon in follow-up, although there is no consistent data on the precise incidence and potential high-risk variables contributing to its occurrence.This study aims to identify the independent risk factors of metabolic bone disease in very low birth weight (VLBW) infants. Methods: Between January 2017 and June 2020, clinical data from 662 newborns with VLBW were retrospectively summarized in 3 pediatric academic centers. Based on the serum alkaline phosphatase and phosphorus levels, infants were split into the MBD and control groups. General health factors, mother birth status, mechanical breathing, enteral nutrition (EN), parenteral nutrition (PN), time on EN, drug use, complications, and biochemical MBD indexes were gathered and compared between the two groups.Results: The prevalence of MBD among the 662 cases was 17.37% in the VLBW infants. The mean birth weight (BW) and gestational age (GA) in the MBD group, were 1083.92±126.25g and 28.07±2.09wk, respectively. Between the two groups, there were significant variations in GA and BW (P < 0.05). When compared to the control group, the MBD group's incidence of IUGR was considerably greater (P < 0.05). Starting EN, PN duration, and mechanical ventilation were significantly different between the two groups (P < 0.05). In infants with VLBW, GA and BW each functioned as a protective factor against MBD. In VLBW newborns, MBD was attributable to three separate risk factors: PN time, commencing EN time, and IUGR.Conclusions: There are numerous contributing variables to MBD. In infants with VLBW, GA and BW each functioned as a protective factor against MBD.
What problem does this paper attempt to address?